Call Buying Activity in Atlassian (TEAM) Targets 6% Upside in Shares into November -Susquehanna

Go back to Call Buying Activity in Atlassian (TEAM) Targets 6% Upside in Shares into November -Susquehanna

Atlassian Corporation (TEAM) PT Lowered to $206 at Goldman Sachs, Following Earnings

October 30, 2020 11:20 AM EDT

Goldman Sachs analyst Heather Bellini lowered the price target on Atlassian Corporation (NASDAQ: TEAM) to $206.00 (from $209.00) while maintaining a Buy rating.

... More

Pre-Open Stock Movers 10/30: (EQ) (TRUP) (PLT) Higher; (AXGT) (COLM) (TWTR) Lower (more...)

October 30, 2020 9:29 AM EDT

Pre-Open Stock Movers:

Axovant Gene Therapies Ltd. (Nasdaq: AXGT) 39.5% LOWER; announced program updates to be presented as part of its virtual R&D Day on Friday, October 30, 2020 at 11:30 AM Eastern time, for the Companys AXO-Lenti-PD gene therapy for Parkinsons disease. Trial pushed back.

Columbia Sportswear (NASDAQ: COLM) 16.4% LOWER; reported Q3 EPS of $0.94, $0.22 worse than the analyst estimate of $1.16. Revenue for the quarter came in at $701.1 million versus the consensus estimate of $767.13 million. Columbia Sportswear sees Q4 2020 EPS... More

Atlassian Corporation (TEAM) PT Raised to $243 at Citi

October 30, 2020 6:13 AM EDT

Citi analyst Walter Pritchard raised the price target on Atlassian Corporation (NASDAQ: TEAM) to $243.00 (from $241.00) while maintaining a Buy rating.... More

Truist Securities Downgrades Atlassian Corporation (TEAM) to Hold

October 30, 2020 6:10 AM EDT

Truist Securities downgraded Atlassian Corporation (NASDAQ: TEAM) from Buy to Hold.


For an analyst ratings summary and ratings history on Atlassian Corporation click here. For more ratings news on Atlassian Corporation click here.


Shares of Atlassian Corporation closed at $199.00 yesterday.

... More

After-Hours Stock Movers 10/29: (EQ) (PLT) (GOOGL) Higher; (AXGT) (COLM) (TWTR) (AAPL) Lower (more...)

October 29, 2020 6:01 PM EDT

After-Hours Stock Movers:

Axovant Gene Therapies Ltd. (Nasdaq: AXGT) 39.5% LOWER; announced program updates to be presented as part of its virtual R&D Day on Friday, October 30, 2020 at 11:30 AM Eastern time, for the Companys AXO-Lenti-PD gene therapy for Parkinsons disease. Trial pushed back.

Columbia Sportswear (NASDAQ: COLM) 16.4% LOWER; reported Q3 EPS of $0.94, $0.22 worse than the analyst estimate of $1.16. Revenue for the quarter came in at $701.1 million versus the consensus estimate of $767.13 million. Columbia Sportswear sees Q4 2020 EPS of $1.07-$1.32,... More

Atlassian (TEAM) Tops Q1 EPS by 3c, Revenues Beat; Offers 2Q EPS/Revenue Guidance Below Consensus

October 29, 2020 4:16 PM EDT

Atlassian (NASDAQ: TEAM) reported Q1 EPS of $0.30, $0.03 better than the analyst estimate of $0.27. Revenue for the quarter came in at $459.5 million versus the consensus estimate of $440.41 million.

We drove strong results in Q1, generating $460 million in revenue, growth of 26% from the prior year, said Scott Farquhar, Atlassians co-founder and co-CEO. We also added more than 8,600 net new customers during the quarter, and now serve over 182,000 customers, including more than 160,000 using our cloud products, as we take the... More